Immunotherapy | CHOP Research Institute
 

Immunotherapy

Dr. Wang directs the Cell Based Therapy Lab (CBTL) at CHOP. The CBTL is a cGMP facility manufacturing cell and gene therapy products for use in bone marrow transplant, adoptive immune therapy, and many other cutting edge applications in medicine.

E-mail:
wangy2 [at] chop.edu

The Li Lab develops cutting-edge computational programs for analyzing large cancer genomics data, with a focus on understanding tumor-immune interactions.

Published on
Oct 30, 2024
Adam Wolpaw, MD, PhD, and Timothy Spear, MD, PhD, have been awarded grants from Hyundai Hope On Wheels to improve CAR T-cell therapy.
Published on
Aug 23, 2024
Grab your pompoms and get your game face on as we go Off Campus to Lincoln Financial Field with CHOP research technician Makenna Higgins.
Published on
Apr 12, 2024
This week, AACR names CHOP physician-scientists as grant recipients, and CIRP researchers publish new findings on driving and mood disorders.
Published on
Mar 18, 2024
Learn how the NAD metabolite controls how well T and B cells can detect their antigens, leading to quicker immune responses.
Published on
Mar 5, 2024
Two global teams are developing solid cancer drugs and understanding T-cell receptors.
Published on
Jan 29, 2024
With funding from the National Cancer Institute’s Childhood Cancer Data Initiative, CHOP researchers are identifying new immunotherapy targets.
Published on
Dec 28, 2023
These six stories received the highest number of engagements on CHOP Research social media channels in 2023.
Published on
Nov 20, 2023
The NIH-funded study, PRESCRIBE, will help researchers understand how antibiotics affect organ function recovery and respiratory microbiota in children with sepsis.